Actium BioSystems disclosed today that its novel system platform, ACT, for selectively delivering controlled hyperthermia as an adjuvant to chemotherapy, has been validated via in vivo studies by two ...

Actium BioSystems is testing a novel delivery system for treating cancer that employs both heat and chemotherapy in a selectively targeted attack. Actium is preparing further in vivo studies that will ...

Arrangement pairs one of Canada's most successful biotech executive teams with academic discovery engine to address the need for better drugs targeting cancer stem cells and regenerative medicine.

Lorenzo A. Castro’s painting of the Battle of Actium in 31 BC. Credit: U.K. National Maritime Museum Diplomat author Mercy Kuo regularly engages subject-matter experts, policy practitioners, and ...

Actium BioSystems disclosed that its novel system platform, ACT, for selectively delivering controlled hyperthermia as an adjuvant to chemotherapy, has been validated via in vivo studies by two ...